Vanda Reports Positive Phase 3 Results For Tradipitant In Motion Sickness
15 May 2024 //
PR NEWSWIRE
Vanda Announces that FDA Accepts NDA for Tradipitant for Gastroparesis
05 Dec 2023 //
PR NEWSWIRE
Vanda’s tradipitant shows improvement in Covid-19 patients
18 Aug 2020 //
CLINICALTRIALSARENA
FDA grants authorization for Individual Patient Expanded Access Protocol
13 Jul 2020 //
PRNEWSWIRE
Vanda Announces the Initiation of ODYSSEY,FDA Approved Study of Tradipitant
02 Apr 2020 //
PRNEWSWIRE